Vitamine D et auto-immunité. Première partie : aspects fondamentaux

La Revue de Médecine Interne - Tập 33 - Trang 80-86 - 2012
Y. Schoindre1, B. Terrier2, J.-E. Kahn1, D. Saadoun2, J.-C. Souberbielle3, O. Benveniste4, Z. Amoura2, J.-C. Piette2, P. Cacoub2, N. Costedoat-Chalumeau2
1Service de médecine interne, université Versailles Saint-Quentin-en-Yvelines, hôpital Foch, 40, rue Worth, 92151 Suresnes cedex, France
2Service de médecine interne, université Pierre-et-Marie-Curie Paris-6, centre de référence national pour le lupus systémique et le syndrome des antiphospholipides, hôpital Pitié-Salpêtrière, Assistance publique–Hôpitaux de Paris, 47-83, boulevard de l’Hôpital, 75651 Paris cedex 13, France
3Laboratoire de physiologie, université Paris-Descartes, hôpital Necker-Enfants–Malades, Assistance publique–Hôpitaux de Paris, 149, rue de Sèvres, 75743 Paris cedex 15, France
4Service de médecine interne 1, université Pierre-et-Marie-Curie–Paris-6, hôpital Pitié-Salpêtrière, Assistance publique–Hôpitaux de Paris, 47-83, boulevard de l’Hôpital, 75651 Paris cedex 13, France

Tài liệu tham khảo

Arnson, 2007, Vitamin D and autoimmunity: new aetiological and therapeutic considerations, Ann Rheum Dis, 66, 1137, 10.1136/ard.2007.069831 Bouillon, 2008, Vitamin D and human health: lessons from vitamin D receptor null mice, Endocr Rev, 29, 726, 10.1210/er.2008-0004 Holick, 2007, Vitamin D deficiency, N Engl J Med, 357, 266, 10.1056/NEJMra070553 Zhou, 2006, Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia, J Clin Invest, 116, 1703, 10.1172/JCI27793 Cannell, 2008, On the epidemiology of influenza, Virol J, 5, 29, 10.1186/1743-422X-5-29 Souberbielle, 2006, Evaluating vitamin D status. Implications for preventing and managing osteoporosis and other chronic diseases, Joint Bone Spine, 73, 249, 10.1016/j.jbspin.2006.01.003 Smolders, 2009, Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis, J Neuroimmunol, 207, 117, 10.1016/j.jneuroim.2008.12.011 Wang, 2010, Common genetic determinants of vitamin D insufficiency: a genome-wide association study, Lancet, 376, 180, 10.1016/S0140-6736(10)60588-0 Mithal, 2009, Global vitamin D status and determinants of hypovitaminosis D, Osteoporos Int, 20, 1807, 10.1007/s00198-009-0954-6 Hagenau, 2009, Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis, Osteoporos Int, 20, 133, 10.1007/s00198-008-0626-y Holick, 2005, Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy, J Clin Endocrinol Metab, 90, 3215, 10.1210/jc.2004-2364 Mora, 2008, Vitamin effects on the immune system: vitamins A and D take centre stage, Nat Rev Immunol, 8, 685, 10.1038/nri2378 Adorini, 2009, Induction of tolerogenic dendritic cells by vitamin D receptor agonists, Handb Exp Pharmacol, 251, 10.1007/978-3-540-71029-5_12 Unger, 2009, Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1, Eur J Immunol, 39, 3147, 10.1002/eji.200839103 Szeles, 2009, 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype, J Immunol, 182, 2074, 10.4049/jimmunol.0803345 Enioutina, 2008, TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines, Vaccine, 26, 601, 10.1016/j.vaccine.2007.11.084 Penna, 2005, Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T-cells by 1,25-dihydroxyvitamin D3, Blood, 106, 3490, 10.1182/blood-2005-05-2044 van Halteren, 2002, Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3), Diabetes, 51, 2119, 10.2337/diabetes.51.7.2119 van Halteren, 2004, 1alpha, 25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T-cells via the selective induction of apoptosis, J Autoimmun, 23, 233, 10.1016/j.jaut.2004.06.004 Zanoni, 2011, The regulatory role of dendritic cells in the induction and maintenance of T-cell tolerance, Autoimmunity, 44, 23, 10.3109/08916931003782148 Israni, 2009, Interaction of vitamin D receptor with HLA DRB1*0301 in type 1 diabetes patients from North India, PLoS One, 4, e8023, 10.1371/journal.pone.0008023 Ramagopalan, 2009, Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D, PLoS Genet, 5, e1000369, 10.1371/journal.pgen.1000369 Rahman, 2008, Systemic lupus erythematosus, N Engl J Med, 358, 929, 10.1056/NEJMra071297 Meyer, 2008, Lupus érythémateux systémique., 123 Wing, 2010, Regulatory T-cells exert checks and balances on self tolerance and autoimmunity, Nat Immunol, 11, 7, 10.1038/ni.1818 Buckner, 2010, Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T-cells in human autoimmune diseases, Nat Rev Immunol, 10, 849, 10.1038/nri2889 Baeke, 2011, The vitamin D analog, TX527, promotes a human CD4+CD25 high CD127 low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation, J Immunol, 186, 132, 10.4049/jimmunol.1000695 Jeffery, 2009, 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T-cells expressing CTLA-4 and FoxP3, J Immunol, 183, 5458, 10.4049/jimmunol.0803217 Cippitelli, 1998, Vitamin D3: a transcriptional modulator of the interferon-gamma gene, Eur J Immunol, 28, 3017, 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.0.CO;2-6 Smolders, 2009, Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis, PLoS One, 4, e6635, 10.1371/journal.pone.0006635 Smolders, 2010, Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis, J Steroid Biochem Mol Biol, 121, 243, 10.1016/j.jsbmb.2010.03.001 Chen, 2007, Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation, J Immunol, 179, 1634, 10.4049/jimmunol.179.3.1634 Heine, 2008, 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells, Eur J Immunol, 38, 2210, 10.1002/eji.200838216 Linker-Israeli, 2001, Vitamin D(3) and its synthetic analogs inhibit the spontaneous in vitro immunoglobulin production by SLE-derived PBMC, Clin Immunol, 99, 82, 10.1006/clim.2000.4998 Coulombe, 2009, Crohn's disease as an immune deficiency?, Lancet, 374, 769, 10.1016/S0140-6736(09)61576-2 Fritz, 2011, Crohn's disease: NOD2, autophagy and ER stress converge, Gut, 60, 1580, 10.1136/gut.2009.206466 Cooney, 2010, NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation, Nat Med, 16, 90, 10.1038/nm.2069 Jéru, 2011, Inflammasome et interleukine 1, Rev Med Interne, 32, 218, 10.1016/j.revmed.2010.02.013 Travassos, 2010, Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry, Nat Immunol, 11, 55, 10.1038/ni.1823 Levine, 2011, Autophagy in immunity and inflammation, Nature, 469, 323, 10.1038/nature09782 Wang, 2010, Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease, J Biol Chem, 285, 2227, 10.1074/jbc.C109.071225 Verway, 2010, Vitamin D, NOD2, autophagy and Crohn's disease, Expert Rev Clin Immunol, 6, 505, 10.1586/eci.10.31